Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Predictive Factors of Death and the Clinical Profile of Hospitalized Covid-19 Patients in Morocco: A One-Year Mixed Cohort Study

Charif et al., Cureus, doi:10.7759/cureus.32462
Dec 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality, HCQ 27% Improvement Relative Risk HCQ for COVID-19  Charif et al.  LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 615 patients in Morocco (August 2020 - September 2021) Lower mortality with HCQ (p=0.00054) c19hcq.org Charif et al., Cureus, December 2022 FavorsHCQ Favorscontrol 0 0.5 1 1.5 2+
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020, now with p < 0.00000000001 from 421 studies, recognized in 56 countries.
No treatment is 100% effective. Protocols combine treatments.
5,400+ studies for 117 treatments. c19hcq.org
Retrospective 615 hospitalized COVID-19 patients in Morocco, showing lower mortality with HCQ in unadjusted results.
This study is excluded in the after exclusion results of meta analysis: unadjusted results with no group details.
risk of death, 27.2% lower, RR 0.73, p < 0.001, treatment 138 of 358 (38.5%), control 136 of 257 (52.9%), NNT 7.0, HCQ vs. no HCQ.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Charif et al., 13 Dec 2022, retrospective, Morocco, peer-reviewed, mean age 62.5, 10 authors, study period August 2020 - September 2021. Contact: faiza.charif@gmail.com.
This PaperHCQAll
Predictive Factors of Death and the Clinical Profile of Hospitalized Covid-19 Patients in Morocco: A One-Year Mixed Cohort Study
Faïza Charif, Zaynab Mahdi, Fadila Bousgheiri, Hassana Belafki, Adil Gourinda, Karima Sammoud, Fadila Salmane, Wiam Ftouh, Mariem Benkacem, Adil Najdi
Cureus, doi:10.7759/cureus.32462
Background Since the onset of the Covid-19 pandemic, several studies have been conducted around the world in an attempt to understand this heterogeneous and unpredictable disease and to prevent related death. It was therefore necessary to study the associated risk factors of Covid-19-related mortality. Objectives The aim of this study was to describe the clinical profile and to identify the factors associated with mortality of patients with Covid-19 in Morocco. Methods We performed a mixed cohort study (retrospective and prospective) of 615 in-patients with Covid-19 disease, enrolled between August 2020 and October 2021. We followed the cohort throughout the hospitalization until discharge and 30 days thereafter. Results The median age was 64 years old; 62.1% of the patients were male. The mean time from symptom onset to hospitalization was 8.5 days (±4.67), and 68.1% of patients had comorbidities. On admission, the most common symptoms were dyspnea (82.2%), cough (80.3%), and fever (76.8%). The main follow-up complication was secondary infection (56.9%). Based on univariate analysis, male gender (p<0.008 and brut relative risk { b RR}=1.57), advanced age (p<0.001), lung involvement (p<0.001), lymphopenia (p<0.001 and b RR=2.32), D-dimers of >500 µg/l (p<0.007 and b RR=2.47), C-reactive protein (CRP) of >130 mg/l (p<0.001 and b RR=2.45), elevated creatinine (p<0.013 and b RR=1.61), lactate dehydrogenase (LDH) of >500 U/l (p<0.001 and b RR=7.16), receiving corticosteroids (p<0.001 and b RR=5.08), invasive ventilation (p<0.001 and b RR=30.10), the stay in the resuscitation unit (p<0.001 and b RR=13.37), and acute respiratory distress syndrome (ARDS) (p<0.001 and b RR=10.98) were associated with a higher risk of death. In the opposite, receiving azithromycin and hydroxychloroquine (p<0.001 and b RR=0.28) and pre-admission anticoagulants (p<0.005 and b RR=0.46) was associated with a lower risk of mortality. Multivariate regression analysis showed that age of >60 years (p<0.001 and adjusted odds ratio {aOR}=4.90), the use of invasive ventilation (p<0.001 and aOR=9.60), the stay in the resuscitation unit (p<0.001 and aOR=5.09), and acute respiratory distress syndrome (p<0.001 and aOR=6.49) were independent predictors of Covid-19 mortality. Conclusion In this cohort study focusing on Covid-19 in-patient's mortality, we found that age of >60 years, the use of invasive ventilation, the stay in the resuscitation unit, and acute respiratory distress syndrome were independent predictors of Covid-19 mortality. The results of this study can be used to improve knowledge for better clinical management of Covid-19 in-patients.
Conclusions In this cohort study that focused on Covid-19 in-patient's mortality, we found that age of >60 years, the use of invasive ventilation, the stay in the resuscitation unit, and acute respiratory distress syndrome were independent predictors of Covid-19 mortality. These outcomes can be used to improve the clinical management of patients. Additional Information Disclosures Human subjects: Consent was obtained or waived by all participants in this study. Fes University Hospital Ethics Committee issued approval 03/21. By the unanimous vote of the members present, the committee adopted the following deliberation: favorable opinion. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
References
Aksel, İslam, Algın, Eroğlu, Yaşar et al., Early predictors of mortality for moderate to severely ill patients with Covid-19, Am J Emerg Med, doi:10.1016/j.ajem.2020.08.076
Albitar, Ballouze, Ooi, Ghadzi, Risk factors for mortality among COVID-19 patients, Diabetes Res Clin Pract, doi:10.1016/j.diabres.2020.108293
Alharthy, Aletreby, Faqihi, Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study, J Epidemiol Glob Health, doi:10.2991/jegh.k.200928.001
Bertsimas, Lukin, Mingardi, COVID-19 mortality risk assessment: an international multi-center study, PLoS One, doi:10.1371/journal.pone.0243262
Bienvenu, Noonan, Wang, Peter, Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities, Cardiovasc Res, doi:10.1093/cvr/cvaa284
El Aidaoui, Haoudar, Khalis, Predictors of severity in Covid-19 patients in Casablanca, Morocco, Cureus, doi:10.7759/cureus.10716
Farsalinos, Barbouni, Niaura, Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?, Intern Emerg Med, doi:10.1007/s11739-020-02355-7
Francone, Iafrate, Masci, Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis, Eur Radiol, doi:10.1007/s00330-020-07033-y
Guan, Ni, Hu, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, doi:10.1056/NEJMoa2002032
Hernández-Garduño, Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A casecontrol study, Obes Res Clin Pract, doi:10.1016/j.orcp.2020.06.001
Huang, Wang, Li, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, doi:10.1016/S0140-6736(20)30183-5
Khamis, Memish, Bahrani, Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection, J Infect Public Health, doi:10.1016/j.jiph.2021.03.016
Khosravi, Aghaghazvini, Sorouri, Predictive value of initial CT scan for various adverse outcomes in patients with COVID-19 pneumonia, Heart Lung, doi:10.1016/j.hrtlng.2020.10.005
Kokturk, Babayigit, Kul, The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients, Respir Med, doi:10.1016/j.rmed.2021.106433
Li, Xu, Yu, Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan, J Allergy Clin Immunol, doi:10.1016/j.jaci.2020.04.006
Merugu, Nesheiwat, Balla, Predictors of mortality in 217 COVID-19 patients in Northwest Ohio, United States: a retrospective study, J Med Virol, doi:10.1002/jmv.26750
Mesas, Cavero-Redondo, Álvarez-Bueno, Cabrera, De Andrade et al., Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions, PLoS One, doi:10.1371/journal.pone.0241742
Nadkarni, Bagiella, Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19, J Am Coll Cardiol, doi:10.1016/j.jacc.2020.08.041
Pan, Ye, Sun, Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19), Radiology, doi:10.1148/radiol.2020200370
Richardson, Hirsch, Narasimhan, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA, doi:10.1001/jama.2020.6775
Siddiqi, Libby, Ridker, COVID-19 -a vascular disease, Trends Cardiovasc Med, doi:10.1016/j.tcm.2020.10.005
Xing, Tu, Liu, Efficacy and safety of COVID-19 vaccines: a systematic review, Zhongguo Dang Dai Er Ke Za Zhi, doi:10.7499/j.issn.1008-8830.2101133
Yang, Yu, Xu, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, doi:10.1016/S2213-2600(20)30079-5
Yuan, Yin, Tao, Tan, Hu, Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China, PLoS One, doi:10.1371/journal.pone.0230548
Zhou, Yu, Du, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, doi:10.1016/S0140-6736(20)30566-3
DOI record: { "DOI": "10.7759/cureus.32462", "ISSN": [ "2168-8184" ], "URL": "http://dx.doi.org/10.7759/cureus.32462", "author": [ { "affiliation": [], "family": "Charif", "given": "Faïza", "sequence": "first" }, { "affiliation": [], "family": "Mahdi", "given": "Zaynab", "sequence": "additional" }, { "affiliation": [], "family": "Bousgheiri", "given": "Fadila", "sequence": "additional" }, { "affiliation": [], "family": "Belafki", "given": "Hassana", "sequence": "additional" }, { "affiliation": [], "family": "Gourinda", "given": "Adil", "sequence": "additional" }, { "affiliation": [], "family": "Sammoud", "given": "Karima", "sequence": "additional" }, { "affiliation": [], "family": "Salmane", "given": "Fadila", "sequence": "additional" }, { "affiliation": [], "family": "Ftouh", "given": "Wiam", "sequence": "additional" }, { "affiliation": [], "family": "Benkacem", "given": "Mariem", "sequence": "additional" }, { "affiliation": [], "family": "Najdi", "given": "Adil", "sequence": "additional" } ], "container-title": "Cureus", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2022, 12, 13 ] ], "date-time": "2022-12-13T08:21:59Z", "timestamp": 1670919719000 }, "deposited": { "date-parts": [ [ 2022, 12, 13 ] ], "date-time": "2022-12-13T08:22:09Z", "timestamp": 1670919729000 }, "indexed": { "date-parts": [ [ 2022, 12, 13 ] ], "date-time": "2022-12-13T08:41:16Z", "timestamp": 1670920876203 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2022, 12, 13 ] ] }, "language": "en", "link": [ { "URL": "https://www.cureus.com/articles/122896-predictive-factors-of-death-and-the-clinical-profile-of-hospitalized-covid-19-patients-in-morocco-a-one-year-mixed-cohort-study", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "4492", "original-title": [], "prefix": "10.7759", "published": { "date-parts": [ [ 2022, 12, 13 ] ] }, "published-print": { "date-parts": [ [ 2022, 12, 13 ] ] }, "publisher": "Cureus, Inc.", "reference": [ { "key": "ref1", "unstructured": "WHO coronavirus (COVID-19) dashboard. (2022). Accessed. March 24, 2022: https://covid19.who.int/." }, { "key": "ref2", "unstructured": "Le Portail Officiel du Coronavirus au Maroc. (2022). Accessed. March 24, 2022: http://www.covidmaroc.ma/Pages/Accueilfr.aspx." }, { "DOI": "10.1016/S0140-6736(20)30566-3", "article-title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study", "author": "Zhou F", "doi-asserted-by": "publisher", "journal-title": "Lancet", "key": "ref3", "unstructured": "Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016/S0140-6736(20)30566-3", "volume": "395", "year": "2020" }, { "DOI": "10.1016/j.jaci.2020.04.006", "article-title": "Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan", "author": "Li X", "doi-asserted-by": "publisher", "journal-title": "J Allergy Clin Immunol", "key": "ref4", "unstructured": "Li X, Xu S, Yu M, et al.. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020, 146:110-8. 10.1016/j.jaci.2020.04.006", "volume": "146", "year": "2020" }, { "key": "ref5", "unstructured": "Covid-19 et infection au SARS-CoV-2. manuel de procédures de veille et de riposte. (2021). https://www.sante.gov.ma/Publications/Guides-Manuels/Documents/2021/Manuel-Proc%C3%A9dures_VF.pdf?utm_medium=email&amp;ut...." }, { "DOI": "10.1016/S0140-6736(20)30183-5", "article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", "author": "Huang C", "doi-asserted-by": "publisher", "journal-title": "Lancet", "key": "ref6", "unstructured": "Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016/S0140-6736(20)30183-5", "volume": "395", "year": "2020" }, { "key": "ref7", "unstructured": "World Health Organization ISARIC. COVID-19 core case report form. (2020). Accessed: March 24, 2022: https://isaric.org/wp-content/uploads/2021/02/ISARIC-WHO-COVID-19-CORE-CRF_EN.pdf." }, { "DOI": "10.1016/j.rmed.2021.106433", "article-title": "The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients", "author": "Kokturk N", "doi-asserted-by": "publisher", "journal-title": "Respir Med", "key": "ref8", "unstructured": "Kokturk N, Babayigit C, Kul S, et al.. The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients. Respir Med. 2021, 183:106433. 10.1016/j.rmed.2021.106433", "volume": "183", "year": "2021" }, { "DOI": "10.1016/j.jiph.2021.03.016", "article-title": "Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection", "author": "Khamis F", "doi-asserted-by": "publisher", "journal-title": "J Infect Public Health", "key": "ref9", "unstructured": "Khamis F, Memish Z, Bahrani MA, et al.. Prevalence and predictors of in-hospital mortality of patients hospitalized with COVID-19 infection. J Infect Public Health. 2021, 14:759-65. 10.1016/j.jiph.2021.03.016", "volume": "14", "year": "2021" }, { "DOI": "10.1016/j.diabres.2020.108293", "article-title": "Risk factors for mortality among COVID-19 patients", "author": "Albitar O", "doi-asserted-by": "publisher", "journal-title": "Diabetes Res Clin Pract", "key": "ref10", "unstructured": "Albitar O, Ballouze R, Ooi JP, Sheikh Ghadzi SM. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract. 2020, 166:108293. 10.1016/j.diabres.2020.108293", "volume": "166", "year": "2020" }, { "DOI": "10.1093/cvr/cvaa284", "article-title": "Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities", "author": "Bienvenu LA", "doi-asserted-by": "publisher", "journal-title": "Cardiovasc Res", "key": "ref11", "unstructured": "Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020, 116:2197-206. 10.1093/cvr/cvaa284", "volume": "116", "year": "2020" }, { "DOI": "10.1002/jmv.26750", "article-title": "Predictors of mortality in 217 COVID-19 patients in Northwest Ohio, United States: a retrospective study", "author": "Merugu GP", "doi-asserted-by": "publisher", "journal-title": "J Med Virol", "key": "ref12", "unstructured": "Merugu GP, Nesheiwat Z, Balla M, et al.. Predictors of mortality in 217 COVID-19 patients in Northwest Ohio, United States: a retrospective study. J Med Virol. 2021, 93:2875-82. 10.1002/jmv.26750", "volume": "93", "year": "2021" }, { "DOI": "10.1016/j.ajem.2020.08.076", "article-title": "Early predictors of mortality for moderate to severely ill patients with Covid-19", "author": "Aksel G", "doi-asserted-by": "publisher", "journal-title": "Am J Emerg Med", "key": "ref13", "unstructured": "Aksel G, İslam MM, Algın A, Eroğlu SE, Yaşar GB, Ademoğlu E, Dölek ÜC. Early predictors of mortality for moderate to severely ill patients with Covid-19. Am J Emerg Med. 2021, 45:290-6. 10.1016/j.ajem.2020.08.076", "volume": "45", "year": "2021" }, { "DOI": "10.2991/jegh.k.200928.001", "article-title": "Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study", "author": "Alharthy A", "doi-asserted-by": "publisher", "journal-title": "J Epidemiol Glob Health", "key": "ref14", "unstructured": "Alharthy A, Aletreby W, Faqihi F, et al.. Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study. J Epidemiol Glob Health. 2021, 11:98-104. 10.2991/jegh.k.200928.001", "volume": "11", "year": "2021" }, { "DOI": "10.1007/s00134-020-06294-x", "article-title": "Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study", "author": "COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators", "doi-asserted-by": "publisher", "journal-title": "Intensive Care Med", "key": "ref15", "unstructured": "COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021, 47:60-73. 10.1007/s00134-020-06294-x", "volume": "47", "year": "2021" }, { "DOI": "10.1007/s11739-020-02355-7", "article-title": "Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?", "author": "Farsalinos K", "doi-asserted-by": "publisher", "journal-title": "Intern Emerg Med", "key": "ref16", "unstructured": "Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?. Intern Emerg Med. 2020, 15:845-52. 10.1007/s11739-020-02355-7", "volume": "15", "year": "2020" }, { "DOI": "10.1371/journal.pone.0241742", "article-title": "Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions", "author": "Mesas AE", "doi-asserted-by": "publisher", "journal-title": "PLoS One", "key": "ref17", "unstructured": "Mesas AE, Cavero-Redondo I, Álvarez-Bueno C, Sarriá Cabrera MA, Maffei de Andrade S, Sequí-Dominguez I, Martínez-Vizcaíno V. Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One. 2020, 15:e0241742. 10.1371/journal.pone.0241742", "volume": "15", "year": "2020" }, { "DOI": "10.1016/j.orcp.2020.06.001", "article-title": "Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study", "author": "Hernández-Garduño E", "doi-asserted-by": "publisher", "journal-title": "Obes Res Clin Pract", "key": "ref18", "unstructured": "Hernández-Garduño E. Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study. Obes Res Clin Pract. 2020, 14:375-9. 10.1016/j.orcp.2020.06.001", "volume": "14", "year": "2020" }, { "DOI": "10.7499/j.issn.1008-8830.2101133", "article-title": "Efficacy and safety of COVID-19 vaccines: a systematic review", "author": "Xing K", "doi-asserted-by": "publisher", "journal-title": "Zhongguo Dang Dai Er Ke Za Zhi", "key": "ref19", "unstructured": "Xing K, Tu XY, Liu M, et al.. Efficacy and safety of COVID-19 vaccines: a systematic review. Zhongguo Dang Dai Er Ke Za Zhi. 2021, 23:221-8. 10.7499/j.issn.1008-8830.2101133", "volume": "23", "year": "2021" }, { "DOI": "10.7759/cureus.10716", "article-title": "Predictors of severity in Covid-19 patients in Casablanca, Morocco", "author": "El Aidaoui K", "doi-asserted-by": "publisher", "journal-title": "Cureus", "key": "ref20", "unstructured": "El Aidaoui K, Haoudar A, Khalis M, et al.. Predictors of severity in Covid-19 patients in Casablanca, Morocco. Cureus. 2020, 12:e10716. 10.7759/cureus.10716", "volume": "12", "year": "2020" }, { "DOI": "10.1001/jama.2020.6775", "article-title": "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area", "author": "Richardson S", "doi-asserted-by": "publisher", "journal-title": "JAMA", "key": "ref21", "unstructured": "Richardson S, Hirsch JS, Narasimhan M, et al.. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020, 323:2052-9. 10.1001/jama.2020.6775", "volume": "323", "year": "2020" }, { "DOI": "10.1371/journal.pone.0230548", "article-title": "Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China", "author": "Yuan M", "doi-asserted-by": "publisher", "journal-title": "PLoS One", "key": "ref22", "unstructured": "Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS One. 2020, 15:e0230548. 10.1371/journal.pone.0230548", "volume": "15", "year": "2020" }, { "DOI": "10.1007/s00330-020-07033-y", "article-title": "Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis", "author": "Francone M", "doi-asserted-by": "publisher", "journal-title": "Eur Radiol", "key": "ref23", "unstructured": "Francone M, Iafrate F, Masci GM, et al.. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020, 30:6808-17. 10.1007/s00330-020-07033-y", "volume": "30", "year": "2020" }, { "DOI": "10.1148/radiol.2020200370", "article-title": "Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19)", "author": "Pan F", "doi-asserted-by": "publisher", "journal-title": "Radiology", "key": "ref24", "unstructured": "Pan F, Ye T, Sun P, et al.. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020, 295:715-21. 10.1148/radiol.2020200370", "volume": "295", "year": "2020" }, { "DOI": "10.1016/j.hrtlng.2020.10.005", "article-title": "Predictive value of initial CT scan for various adverse outcomes in patients with COVID-19 pneumonia", "author": "Khosravi B", "doi-asserted-by": "publisher", "journal-title": "Heart Lung", "key": "ref25", "unstructured": "Khosravi B, Aghaghazvini L, Sorouri M, et al.. Predictive value of initial CT scan for various adverse outcomes in patients with COVID-19 pneumonia. Heart Lung. 2021, 50:13-20. 10.1016/j.hrtlng.2020.10.005", "volume": "50", "year": "2021" }, { "DOI": "10.1016/S2213-2600(20)30079-5", "article-title": "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study", "author": "Yang X", "doi-asserted-by": "publisher", "journal-title": "Lancet Respir Med", "key": "ref26", "unstructured": "Yang X, Yu Y, Xu J, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020, 8:475-81. 10.1016/S2213-2600(20)30079-5", "volume": "8", "year": "2020" }, { "DOI": "10.1056/NEJMoa2002032", "article-title": "Clinical characteristics of coronavirus disease 2019 in China", "author": "Guan WJ", "doi-asserted-by": "publisher", "journal-title": "N Engl J Med", "key": "ref27", "unstructured": "Guan WJ, Ni ZY, Hu Y, et al.. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020, 382:1708-20. 10.1056/NEJMoa2002032", "volume": "382", "year": "2020" }, { "DOI": "10.1371/journal.pone.0243262", "article-title": "COVID-19 mortality risk assessment: an international multi-center study", "author": "Bertsimas D", "doi-asserted-by": "publisher", "journal-title": "PLoS One", "key": "ref28", "unstructured": "Bertsimas D, Lukin G, Mingardi L, et al.. COVID-19 mortality risk assessment: an international multi-center study. PLoS One. 2020, 15:e0243262. 10.1371/journal.pone.0243262", "volume": "15", "year": "2020" }, { "DOI": "10.1016/j.tcm.2020.10.005", "article-title": "COVID-19 - a vascular disease", "author": "Siddiqi HK", "doi-asserted-by": "publisher", "journal-title": "Trends Cardiovasc Med", "key": "ref29", "unstructured": "Siddiqi HK, Libby P, Ridker PM. COVID-19 - a vascular disease. Trends Cardiovasc Med. 2021, 31:1-5. 10.1016/j.tcm.2020.10.005", "volume": "31", "year": "2021" }, { "DOI": "10.1016/j.jacc.2020.08.041", "article-title": "Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19", "author": "Nadkarni GN", "doi-asserted-by": "publisher", "journal-title": "J Am Coll Cardiol", "key": "ref30", "unstructured": "Nadkarni GN, Lala A, Bagiella E, et al.. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol. 2020, 76:1815-26. 10.1016/j.jacc.2020.08.041", "volume": "76", "year": "2020" } ], "reference-count": 30, "references-count": 30, "relation": {}, "resource": { "primary": { "URL": "https://www.cureus.com/articles/122896-predictive-factors-of-death-and-the-clinical-profile-of-hospitalized-covid-19-patients-in-morocco-a-one-year-mixed-cohort-study" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Aerospace Engineering" ], "subtitle": [], "title": "Predictive Factors of Death and the Clinical Profile of Hospitalized Covid-19 Patients in Morocco: A One-Year Mixed Cohort Study", "type": "journal-article" }
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit